Loading...
The Financial Express

Health

Pfizer-BioNTech testing booster of their COVID-19 vaccine in new trial

Pfizer Inc and BioNTech SE said on Thursday they are testing a third dose of their COVID-19 vaccine to better understand the immune response against new variants of the virus. They are also in talks with regulatory authorities about testing...

Johnson & Johnson’s one-dose vaccine works well

The one-shot coronavirus vaccine made by Johnson & Johnson provides...

Vaccine-takers’ rush overwhelms health authorities

The rush for getting Covid-19 jabs has put the state-run...

Study suggests Pfizer, Oxford vaccines highly effective against coronavirus

Scotland’s vaccination drive appears to be markedly reducing the risk...

GSK, Sanofi start new clinical trial of protein-based COVID-19 vaccine candidate

GlaxoSmithKline and Sanofi on Monday said they had started a...

WHO believes badgers, rabbits could have spread COVID-19 to humans

World Health Organization (WHO) experts investigating the pandemic's origins suggest...

130 countries haven't received single Covid-19 vaccine dose, UN says

United Nations chief Antonio Guterres on Wednesday (local time) slammed...

WHO gives emergency use approval to AstraZeneca COVID-19 vaccine

The World Health Organization (WHO) has given the green light...

Oxford University to test vaccine response among children

The University of Oxford has launched a study to assess...

All hypotheses still open in probe into virus origins: WHO

All hypotheses are still open in the World Health Organization’s...

Global vaccination strategy 'self-defeating': UNICEF-WHO joint statement

Of the 128 million vaccine doses administered so far, more...

Two masks protect better than one!

The following is a roundup of some of the latest...

WHO's Wuhan probe concludes, US-China disputing over Covid continues

China called on the United States on Wednesday to invite...

‘Lab leak very unlikely as COVID source’

The head of the World Health Organization-led team of experts...

WHO official sees possibility of cold-chain transmission of coronavirus

The head of the World Health Organization-led team in the...

New DARPin drugs show promise

The following is a roundup of some of the latest...

25pc children in India may have Covid antibodies, finds study

India survey finds a quarter of children may have COVID...

Serum Institute will supply 1.1b vaccine doses to COVAX scheme

India's Serum Institute will supply 1.1 billion doses of COVID-19...

Vaccine distribution plan under COVAX scheme to be published soon

Figures for the doses of COVID-19 vaccines being allocated mainly...

AstraZeneca, Oxford expect 'next generation' vaccine

AstraZeneca and University of Oxford aim to produce the next...

Russia's Sputnik V vaccine 91.6pc effective in late-stage trial

Breast cancer now more common than lung, WHO says

Bangladeshi researchers find new corona variant

Oxford kept COVID-19 vaccine trial volunteers in dark about dosing error

Scientists figure out how coronavirus so quickly damages lung cells

Two silent-killer daily life habits  

Leprosy still infects 4,000 people every year in Bangladesh

About 4,000 fresh leprosy cases are being detected every year in Bangladesh and almost eight per cent of the patients suffer from leprosy-related disability, according to a document from Leprosy & TB Coordinating Committee (LTCC) on ‘World Leprosy Day-2021’. With a slogan ‘#Beat Leprosy’, the National Leprosy Programme (NLP) and...

‘Coronake Korobo Joy’ campaign held in Cox’s Bazar

Nipah virus in China with up to 75pc fatality rate could be next pandemic: Report

EU reverses plan to restrict vaccine exports through Irish border

© 2021 - All Rights with The Financial Express